STEVENAGE BIOSCIENCE CATALYST
Get an alert when STEVENAGE BIOSCIENCE CATALYST files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-12-31 (in 7mo)
Last filed for 2025-03-31
Confirmation statement due
2027-04-02 (in 11mo)
Last made up 2026-03-19
Watchouts
None on the register
Cash
£2M
-26.8% lowest in 3 filed years
Net assets
£4M
-13.7% lowest in 3 filed years
Employees
17
0% vs 2024
Profit before tax
-£884K
-220.4% lowest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · latest reflected 2025-03-31
| Metric | Trend | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Turnover | £5,094,304 | £5,458,653 | £4,091,025 | |
| Operating profit | £3,565,677 | £612,902 | -£986,341 | |
| Profit before tax | £3,547,401 | £734,333 | -£884,373 | |
| Net profit | £2,824,971 | £613,892 | -£683,178 | |
| Cash | £4,019,795 | £2,109,056 | £1,544,048 | |
| Total assets less current liabilities | £20,900,290 | £20,417,728 | £18,590,836 | |
| Net assets | £4,371,977 | £4,985,871 | £4,302,693 | |
| Equity | £4,371,977 | £4,985,871 | £4,302,693 | |
| Average employees | 15 | 17 | 17 | |
| Wages | — | — | — | |
| Directors' remuneration | £321,434 | £372,747 | £390,472 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31
-
Turnover
-25.1%
£5,458,653 £4,091,025
lowest in 3 filed years
-
Cash
-26.8%
£2,109,056 £1,544,048
lowest in 3 filed years
-
Net assets
-13.7%
£4,985,871 £4,302,693
lowest in 3 filed years
-
Employees
0%
17 17
-
Operating profit
-260.9%
£612,902 -£986,341
lowest in 3 filed years
-
Profit before tax
-220.4%
£734,333 -£884,373
lowest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|---|
| Operating margin | 70.0% | 11.2% | -24.1% | |
| Net margin | 55.5% | 11.2% | -16.7% | |
| Return on capital employed | 17.1% | 3.0% | -5.3% | |
| Gearing (liabilities / total assets) | — | 79.3% | 80.4% | |
| Current ratio | — | 1.52x | 1.06x | |
| Interest cover | 100.70x | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- STEVENAGE BIOSCIENCE CATALYST 2010-08-02 → present
- STEVENAGE BIOSCIENCE PARK 2010-03-19 → 2010-08-02
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors believe that the company is well placed to manage its business risks successfully and they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 11 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DRUMMOND, Lynn, Dr | Director | 2023-05-01 | Aug 1959 | British |
| FORSYTH, Sally Ann, Dr | Director | 2018-03-05 | Jul 1962 | British |
| GREEN, Jonathan Alexander | Director | 2019-08-30 | Mar 1957 | British |
| HUNTER, Ann Jacqueline, Professor | Director | 2020-09-01 | Nov 1956 | British |
| PHADKE, Uday Prabhakar, Dr | Director | 2023-04-03 | Jul 1952 | British |
| RIVERS, Graham Paul | Director | 2023-07-20 | May 1971 | British |
Show 11 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLEN, Dave | Director | 2016-01-01 | 2020-08-31 |
| BAXTER, Allan, Dr | Director | 2010-03-19 | 2015-01-06 |
| BOUCHET, Veronique Anne, Dr | Director | 2012-05-01 | 2022-06-07 |
| COOPER, John | Director | 2010-03-19 | 2016-07-05 |
| NELKI, Daniel | Director | 2016-07-05 | 2017-04-05 |
| PICARDO, Martino | Director | 2011-03-01 | 2017-06-23 |
| RINK, Timothy, Dr | Director | 2010-07-30 | 2012-03-31 |
| TERLOUW, Clare Elizabeth | Director | 2019-08-29 | 2023-01-11 |
| TOMLINSON, Ian Michael | Director | 2011-08-15 | 2020-08-31 |
| WARD, Iain Stuart | Director | 2017-04-05 | 2018-07-31 |
| WHEATCROFT, James Russell | Director | 2020-09-01 | 2023-07-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Glaxosmithkline Research & Development Limited | Corporate entity | Voting 25–50% | 2016-04-06 | Active |
| The Wellcome Trust Limited | Corporate entity | Voting 25–50% | 2016-04-06 | Active |
Filing timeline
Last 20 of 90 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-03 | CH01 | officers | Change person director company with change date | |
| 2026-04-02 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-04-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-01 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-12-17 | AA | accounts | Accounts with accounts type full | |
| 2025-03-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-19 | AA | accounts | Accounts with accounts type full | |
| 2024-03-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-08-30 | AP01 | officers | Appoint person director company with name date | |
| 2023-08-29 | TM01 | officers | Termination director company with name termination date | |
| 2023-08-03 | AA | accounts | Accounts with accounts type small | |
| 2023-08-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-08-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-08-01 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2023-06-08 | AP01 | officers | Appoint person director company with name date | |
| 2023-06-08 | AP01 | officers | Appoint person director company with name date | |
| 2023-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-21 | AD02 | address | Change sail address company with old address new address | |
| 2023-02-07 | TM01 | officers | Termination director company with name termination date | |
| 2022-08-22 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.